Related Experiment Videos
Evidence that oxidative challenges promote neuronal sprouting and cell cycle re-entry
1Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. csa4@po.cwru.edu
Journal of Alzheimer'S Disease : JAD
|September 6, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evidence for the role of gonadotropin hormones in the development of Alzheimer disease.
Cellular and molecular life sciences : CMLS·2005
The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain.
Cellular and molecular life sciences : CMLS·2005
Mitotic and gender parallels in Alzheimer disease: therapeutic opportunities.
Current drug targets·2004
Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.
Annals of human biology·2003
Reactive oxygen: its sources and significance in Alzheimer disease.
Journal of neural transmission. Supplementum·2002
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.
Mechanisms of ageing and development·2001
Development and validation of an amyloid PET dementia of the Alzheimer's type (DAT) score.
Journal of Alzheimer's disease : JAD·2026
Mental illness among persons with and without dementia in continuing care: A multi-jurisdictional, repeated cross-sectional study.
Journal of Alzheimer's disease : JAD·2026
Associations of television viewing, computer use, and Alzheimer's disease among United States adults: A cross-sectional study of NHANES.
Journal of Alzheimer's disease : JAD·2026
Decreased cerebrospinal fluid NDRG2 is associated with non-Alzheimer's disease derived mild cognitive impairment.
Journal of Alzheimer's disease : JAD·2026
G protein‑coupled receptor kinase 4 governs early kidney development via STAT3 and Nhe3a.
International journal of molecular medicine·2026
Neural regulation of tumor immunity: emerging opportunities to enhance cancer immunotherapy.
Experimental & molecular medicine·2026